S&P 500
(0.39%) 5 119.70 points
Dow Jones
(0.36%) 38 377 points
Nasdaq
(0.51%) 16 009 points
Oil
(-1.38%) $82.69
Gas
(4.84%) $2.02
Gold
(0.42%) $2 357.10
Silver
(0.46%) $27.66
Platinum
(4.60%) $964.50
USD/EUR
(-0.25%) $0.932
USD/NOK
(-0.41%) $10.98
USD/GBP
(-0.57%) $0.796
USD/RUB
(1.69%) $93.42

实时更新: Aker BioMarine AS [AKBM.OL]

交易所: OSE 部门: Healthcare 工业: Drug Manufacturers—Specialty & Generic
BUY
70.83%
return 50.99%
SELL
31.25%
return 0.26%
最后更新时间29 Apr 2024 @ 22:25

-1.68% NOK 70.10

购买 489 min ago

@ NOK71.60

发出时间: 29 Apr 2024 @ 17:27


回报率: -2.09%


上一信号: Apr 29 - 15:56


上一信号: 出售


回报率: -0.56 %

Live Chart Being Loaded With Signals

Commentary (29 Apr 2024 @ 22:25):
Our systems believe the stock currently is undervalued by 0.40% compare to its pairs and should correct upwards.
Profile picture for Aker BioMarine AS

Aker BioMarine AS develops, produces, and sells krill-derived ingredients for nutraceutical, dietary supplement, and animal feed applications in Norway, the Americas, the Asia Pacific, Europe, the Middle East, and Africa...

Stats
今日成交量 47 796.00
平均成交量 48 235.00
市值 6.15B
EPS NOK0 ( 2024-04-24 )
下一个收益日期 ( NOK0 ) 2024-07-11
Last Dividend NOK0 ( N/A )
Next Dividend NOK0 ( N/A )
P/E -63.73
ATR14 NOK3.20 (4.53%)
相关性 (AI algo v.1.1b): Undervalued: 0.40% NOK70.98 paired level. (算法实时跟踪最相关股票的变化并提供即时更新)

音量 相关性

長: 0.28 (neutral)
短: 0.00 (neutral)
Signal:(5) Neutral

Aker BioMarine AS 相关性

10 最正相关
PEN.OL0.93
OKEA.OL0.907
SBX.OL0.87
NOL.OL0.861
AKSO.OL0.85
ZAL.OL0.821
SHLF.OL0.819
ODL.OL0.819
ELK.OL0.819
AIRX.OL0.802
10 最负相关
TOM.OL-0.848
CADLR.OL-0.826
KOMP.OL-0.813
ATEA.OL-0.81
HMONY.OL-0.81

你知道吗?

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1,其中-1表示完全负相关(一个变量增加,另一个变量减少),1表示完全正相关(一个变量增加,另一个变量也增加),0表示没有相关性(变量之间没有关系)。

相关性可用于分析任何两个变量之间的关系,而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Aker BioMarine AS 相关性 - 货币/商品

The country flag -0.80
( strong negative )
The country flag -0.25
( neutral )
The country flag 0.00
( neutral )
The country flag -0.69
( moderate negative )
The country flag 0.45
( neutral )
The country flag 0.69
( moderate )

Aker BioMarine AS 财务报表

Annual 2023
营收: NOK335.30M
毛利润: NOK112.90M (33.67 %)
EPS: NOK-0.100
FY 2023
营收: NOK335.30M
毛利润: NOK112.90M (33.67 %)
EPS: NOK-0.100
FY 2022
营收: NOK277.20M
毛利润: NOK114.80M (41.41 %)
EPS: NOK0.110
FY 2021
营收: NOK262.06M
毛利润: NOK88.06M (33.60 %)
EPS: NOK-0.0900

Financial Reports:

No articles found.

Aker BioMarine AS

Aker BioMarine AS develops, produces, and sells krill-derived ingredients for nutraceutical, dietary supplement, and animal feed applications in Norway, the Americas, the Asia Pacific, Europe, the Middle East, and Africa. It operates through two segments, Ingredients and Brands. It provides Superba, a krill-based ingredients for nutraceutical, including phospholipid complex of choline, omega-3s, and antioxidant astaxanthin; QRILL Aqua, a krill-based ingredients for aquaculture; and QRILL Pet, a krill-based ingredients animal feed application. The company also offers LYSOVETA, a delivery platform based on LPC-bound EPA and DHA from krill; and INVI, a hydrolyzed protein isolate for food and beverage applications. In addition, it distributes human health and nutrition products, and natural supplements, as well as provides AION, a circular solution provider that recycles waste and re-use materials. The company was founded in 2006 and is headquartered in Lysaker, Norway. Aker BioMarine ASA is a subsidiary of Aker ASA.

关于 实时信号

此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。

实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。